Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1994-10-28
|
pubmed:abstractText |
A new ultrasensitive chemiluminoenzyme immunoassay (CLEIA) using digoxigenin-labeled bradykinin (BK) as a tracer is proposed to quantify kinins in tissue samples. Rabbit polyclonal IgGs anti-BK directed against the C-terminal end were used for the immunoconcentration step along with dioxetane derivative for the revelation step. The sensitivity of the assay for BK was 0.1 fmol/ml with ED50 of 0.78 pmol/ml. This method was applied on extracts of normal and carrageenan-inflamed tissues. The edema produced by the injection of carrageenan in rat hindpaws was associated with a sevenfold increase of immunoreactive kinins in the inflamed paw extract (from 0.021 +/- 0.007 to 0.141 +/- 0.021 pmol/g tissue; p < 0.01), the immunoreactivity corresponded to BK, kallidin, and T-kinin after HPLC separation. When a mixture of inhibitors of kininase I (mergepta) and kininase II (captopril) was coinjected with carrageenan, the carrageenan-induced edema was unaffected but the kinin tissue content was significantly enhanced (0.207 +/- 0.003 pmol/g tissue; p < 0.01). However, the kinin tissue content and the edema response were unaltered by inhibitors given separately. Hence, this highly sensitive assay provides a biochemical evidence that kinins may act as proinflammatory mediators, and highlights a compensatory increase of kininase I and II activities in inflamed tissues.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-mercaptomethyl-3-guanidinoethylthi...,
http://linkedlifedata.com/resource/pubmed/chemical/3-Mercaptopropionic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Digoxigenin,
http://linkedlifedata.com/resource/pubmed/chemical/Lysine Carboxypeptidase
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0196-9781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
511-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7937327-3-Mercaptopropionic Acid,
pubmed-meshheading:7937327-Acute Disease,
pubmed-meshheading:7937327-Amino Acid Sequence,
pubmed-meshheading:7937327-Animals,
pubmed-meshheading:7937327-Bradykinin,
pubmed-meshheading:7937327-Captopril,
pubmed-meshheading:7937327-Digoxigenin,
pubmed-meshheading:7937327-Disease Models, Animal,
pubmed-meshheading:7937327-Immunoenzyme Techniques,
pubmed-meshheading:7937327-Inflammation,
pubmed-meshheading:7937327-Luminescent Measurements,
pubmed-meshheading:7937327-Lysine Carboxypeptidase,
pubmed-meshheading:7937327-Male,
pubmed-meshheading:7937327-Molecular Sequence Data,
pubmed-meshheading:7937327-Molecular Structure,
pubmed-meshheading:7937327-Rats,
pubmed-meshheading:7937327-Rats, Wistar
|
pubmed:year |
1994
|
pubmed:articleTitle |
Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues.
|
pubmed:affiliation |
Département de Physiologie, Faculté de Médecine, Université de Montréal, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|